Further Press Releases and Documents Relating to the 2016 Alzheimer’s Association International Conference (Alzheimer’s Association International Conference)

Summary

A list of press-releases is available relating to some of the main presentations at the Alzheimer’s Association International Conference, held in Toronto last week.

Full Text Link

Reference

Alzheimer’s Association International Conference^® 2016. List of Press Releases. [Toronto. Online]: Alzheimer’s Association, July 2016.

More From the AAIC2016 Special Collection:

Note: Selected articles may be available freely; others will require a suitable Athens password, a journal subscription or payment for access.

General Information

The Alzheimer’s Association AAIC Press Office has provided a collection of associated publications, pertaining to the 2016 Alzheimer’s Association International Conference (AAIC^®2016).

Alzheimer’s Association (2016). 2016 Alzheimer’s Disease facts and figures. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. April 2016, 12(4), 459-509. Full Text Link.

Snyder, HM. Cardenas-Aguayo, MdC. Alonso, A. [et al] (2016). Alzheimer’s Disease research in Ibero America. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. June 2016, 12(6), 749-754. Full Text Link.

Hendrix, JA. Bateman, RJ. Brashear, HR. [et al] (2016). Challenges, solutions, and recommendations for Alzheimer’s Disease combination therapy. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2016, 12(5), 623-630. Full Text Link.

Weninger, S. Carrillo, MC. Dunn, B. [et al] (2016). Collaboration for Alzheimer’s Prevention: principles to guide data and sample sharing in preclinical Alzheimer’s Disease trials. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2016, 12(5), 631-632. Full Text Link.

Molinuevo, JL. Cami, J. Carné, X. [et al] (2016). Ethical challenges in preclinical Alzheimer’s Disease observational studies and trials: results of the Barcelona summit. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2016, 12(5), 614-622. Full Text Link.

Borson, S. Boustani, MA. Buckwalter, KC. [et al] (2016). Report on milestones for care and support under the U.S. National Plan to Address Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2016, 12(3), 334-369. Full Text Link.

Holtzman, DM. Carrillo, MC. Hendrix, JA. [et al] (2016). Tau: from research to clinical development. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. [Epub ahead of print]. Full Text Link.

Rabinovici, GD. Karlawish, J. Knopman, D. [et al] (2016). Testing and disclosures related to amyloid imaging and Alzheimer’s Disease: common questions and fact sheet summary. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. April 2016, 12(4), 510-515. Full Text Link.

Risk Prevention

Sleegers, K. Bettens, K. De Roeck, A. [et al] (2015). A 22-single nucleotide polymorphism Alzheimer’s Disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ₄₂. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. November 2015, 11(12), 1452-1460. Full Text Link.

ADAPT-FS Research Group (2015). Follow-up evaluation of cognitive function in the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial and its Follow-up Study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. February 2015, 11(2), 216-225. e211. Full Text Link.

Carcaillon, L. Brailly-Tabard, S. Ancelin, ML. [et al] (2014). Low testosterone and the risk of dementia in elderly men: impact of age and education. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2015, 10(5), S306-S314. Full Text Link.

Green, RC. Christensen, KD. Cupples, LA. [et al] (2015). A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. October 2015, 11(10), 1222-1230. Full Text Link.

Lill, CM. Rengmark, A. Pihlstrøm, L. [et al] (2015). The role of TREM2 R47H as a risk factor for Alzheimer’s Disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. December 2015, 11(12), 1407-1416. Full Text Link.

Leoutsakos, J.-MS. Bartlett, AL. Forrester, SN. [et al] (2014). Simulating effects of biomarker enrichment on Alzheimer’s Disease prevention trials: conceptual framework and example. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2014, 10(2), 152-161. Full Text Link.